CSI Market
Sign In | Register

Intellipharmaceutics International Inc (IPCIF) Annual Balance Sheets

Annual · GAAP · USD millions
Access IPCIF quarterly Balance Sheets →
Examining balance sheet movements between Intellipharmaceutics International Inc and Nov 30 2018 reveals how Nov 30 2022 adjusts its asset composition and liability profile.
View historic periods: Download as CSV:
Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.
Annual Report, GAAP in USD millions
ITEM 		(Nov 30 2022)
(Nov 30 2020) (Nov 30 2020) (Nov 30 2019) (Nov 30 2018)
Assets
Cash & cash equivalent0.08
Cash & Short-term Investments0.00
Accounts receivable0.00
Other Receivables0.00
Inventories0.00
Other Current Assets0.27
Prepaid Expense And Other Assets Current0.14
Total Current Assets0.49
Equipment/Property/Plant Net0.79
Tax Assets, Noncurrent0.00
Other Assets, Noncurrent0.00
Tax Credit Carryforward Amount0.27
Operating Lease Right Of Use Asset0.15
Total Assets1.43
Liabilities
Accounts Payable, Current AC3.76
Employee-related Liabilities, Current AC3.07
Notes and Loans Payable, Current LO0.36
Other Liabilities, Current0.00
Taxes Payable, Current, Total0.03
Deferred Revenue, Current DE0.00
Total Current Liabilities7.22
Long-term debt0.00
Convertible Notes Payable NO1.80
Total Long-term Debt1.80
Deferred Revenue, Noncurrent DE0.00
Accrued Income Taxes, Noncurrent0.00
Other liabilities, Noncurrent10.21
Operating Lease Liability Current0.17
Total Liabilities12.01
Stockholders' Equity
Common Stock Value49.18
Additional Paid In Capital Common Stock45.10
Retained Earnings / Accumulated Deficit-105.13
Accumulated Other Comprehensive Income0.00
Other Equity0.28
Common Stockholder's Equity-10.58
Total Stockholder's Equity-10.58
Liabilities & Stockholder's Equity1.43
4 historic quarters locked

Sign in to unlock the full Intellipharmaceutics International Inc balance sheet history.

Sign In Create Free Account

About Intellipharmaceutics International Inc Annual Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0001654954-23-008028

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.